NCT01853358View on ClinicalTrials.gov

Phase I of Infusion of Selected Donor NK Cells After Allogeneic Stem Cell Transplantation

PHASE1CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

March 15, 2018

Study Completion Date

March 15, 2018

Conditions
Hematological Malignancy
Interventions
BIOLOGICAL

NK Cell infusion

"* level 1: 1 x 10e6 NK cells /kg;~* level 2: 5 x 10e6 NK cells /kg;~* level 3: \> 5.10e6 and ≤ 5.10e7 cellules NK/kg"

Trial Locations (1)

13009

Institut Paoli-Calmettes, Marseille

All Listed Sponsors
lead

Institut Paoli-Calmettes

OTHER

NCT01853358 - Phase I of Infusion of Selected Donor NK Cells After Allogeneic Stem Cell Transplantation | Biotech Hunter | Biotech Hunter